Cargando…
Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B
Chronic HBV (CHB) infected patients with intermediate necroinflammation and fibrosis are recommended to receive antiviral treatment. However, other than liver biopsy, there is a lack of sensitive and specific objective method to determine the necroinflammation and fibrosis stages in CHB patients. Th...
Autores principales: | Huang, Haijun, Sun, Zeyu, Pan, Hongying, Chen, Meijuan, Tong, Yongxi, Zhang, Jiajie, Chen, Deying, Su, Xiaoling, Li, Lanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976343/ https://www.ncbi.nlm.nih.gov/pubmed/27498553 http://dx.doi.org/10.1038/srep30853 |
Ejemplares similares
-
Inhibitory effects of genistein in combination with gefitinib on the hepatocellular carcinoma Hep3B cell line
por: Tong, Yongxi, et al.
Publicado: (2019) -
Chemical Isotope Labeling LC-MS for Monitoring Disease Progression and Treatment in Animal Models: Plasma Metabolomics Study of Osteoarthritis Rat Model
por: Chen, Deying, et al.
Publicado: (2017) -
A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients
por: Cano, Ainara, et al.
Publicado: (2017) -
Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination
por: Itoi, Takao, et al.
Publicado: (2017) -
Oral Phosphatidylcholine Improves Intestinal Barrier Function in Drug-Induced Liver Injury in Rats
por: Chen, Meijuan, et al.
Publicado: (2019)